Analysis of tumor mutational burden: correlation of five large gene panels with whole exome sequencing
Abstract Outcome of immune checkpoint inhibition in cancer can be predicted by measuring PDL1 expression of tumor cells. Search for additional biomarkers led to tumor mutational burden (TMB) as surrogate marker for neoantigens presented. While TMB was previously determined via whole exome sequencing...
Main Authors: | Carina Heydt, Jan Rehker, Roberto Pappesch, Theresa Buhl, Markus Ball, Udo Siebolts, Anja Haak, Philipp Lohneis, Reinhard Büttner, Axel M. Hillmer, Sabine Merkelbach-Bruse |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-020-68394-4 |
Similar Items
-
Managing Difficulties of Microsatellite Instability Testing in Endometrial Cancer-Limitations and Advantages of Four Different PCR-Based Approaches
by: Janna Siemanowski, et al.
Published: (2021-03-01) -
Comparison of in situ and extraction-based methods for the detection of MET amplifications in solid tumors
by: Carina Heydt, et al.
Published: (2019-01-01) -
Genomic Characterization of TP53–Wild-Type Esophageal Carcinoma
by: Alexander Quaas, et al.
Published: (2019-01-01) -
Detection of gene fusions using targeted next-generation sequencing: a comparative evaluation
by: Carina Heydt, et al.
Published: (2021-02-01) -
Comparison of pre-analytical FFPE sample preparation methods and their impact on massively parallel sequencing in routine diagnostics.
by: Carina Heydt, et al.
Published: (2014-01-01)